Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice.
Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice.
复制标题
DOI:
10.1172/jci16923
复制
发表时间:
2003-02
期刊:
影响因子:
--
通讯作者:
T. Kaifu;J. Nakahara;M. Inui;K. Mishima;T. Momiyama;Mitsuji Kaji;Akiko Sugahara;H. Koito;Azusa Ujik
中科院分区:
文献类型:
--
作者:
T. Kaifu;J. Nakahara;M. Inui;K. Mishima;T. Momiyama;Mitsuji Kaji;Akiko Sugahara;H. Koito;Azusa Ujik
Deletions in the DAP12 gene in humans result in Nasu-Hakola disease, characterized by a combination of bone fractures and psychotic symptoms similar to schizophrenia, rapidly progressing to presenile dementia. However, it is not known why these disorders develop upon deficiency in DAP12, an immunoreceptor signal activator protein initially identified in the immune system. Here we show that DAP12-deficient (DAP12(-/-)) mice develop an increased bone mass (osteopetrosis) and a reduction of myelin (hypomyelinosis) accentuated in the thalamus. In vitro osteoclast induction from DAP12(-/-) bone marrow cells yielded immature cells with attenuated bone resorption activity. Moreover, immature oligodendrocytes were arrested in the vicinity of the thalamus, suggesting that the primary defects in DAP12(-/-) mice are the developmental arrest of osteoclasts and oligodendrocytes. In addition, the mutant mice also showed synaptic degeneration, impaired prepulse inhibition, which is commonly observed in several neuropsychiatric diseases in humans including schizophrenia, and aberrant electrophysiological profiles in the thalami. These results provide a molecular basis for a unique combination of skeletal and psychotic characteristics of Nasu-Hakola disease as well as for schizophrenia and presenile dementia.